Cargando…
Adipose derived mesenchymal stem cell secretome formulation as a biotherapeutic to inhibit growth of drug resistant triple negative breast cancer
In the present study, a protocol was developed for processing of human adipose derived mesenchymal stem cell secretome formulation of varying concentration. Its molecular composition was evaluated, and its effectiveness in vitro using breast cancer cell lines, and in vivo in a nude mice breast cance...
Autores principales: | Nadesh, Ragima, Menon, Krishnakumar N., Biswas, Lalitha, Mony, Ullas, Subramania Iyer, K., Vijayaraghavan, Sundeep, Nambiar, Ajit, Nair, Shantikumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648896/ https://www.ncbi.nlm.nih.gov/pubmed/34873206 http://dx.doi.org/10.1038/s41598-021-01878-z |
Ejemplares similares
-
Author Correction: Adipose derived mesenchymal stem cell secretome formulation as a biotherapeutic to inhibit growth of drug resistant triple negative breast cancer
por: Nadesh, Ragima, et al.
Publicado: (2023) -
Development and molecular characterization of polymeric micro-nanofibrous scaffold of a defined 3-D niche for in vitro chemosensitivity analysis against acute myeloid leukemia cells
por: Nair, Maya S, et al.
Publicado: (2015) -
Unexplored Excipients in Biotherapeutic Formulations: Natural Osmolytes as Potential Stabilizers Against Thermally Induced Aggregation of IgG1 Biotherapeutics
por: Bhojane, Purva P., et al.
Publicado: (2021) -
Computational models for studying physical instabilities in high concentration biotherapeutic formulations
por: Blanco, Marco A.
Publicado: (2022) -
Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications
por: Kuriakose, Anshu, et al.
Publicado: (2016)